PACS CEO Jason Hulse Murray Sells $5.2M of Stock
PACS Group, Inc. CEO Jason Hulse Murray sold 110,035 shares for about $5.2 million on October 15, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Jason Hulse Murray, Co-Founder, CEO & Chairman at PACS Group, Inc. ($PACS), sold 110,035 shares at an average price of $47.27, worth about $5.20 million, on October 15, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.
Since the trade, $PACS is down 1.8% to date (from the $47.75 close on Oct 15, 2026).
Key Points
- PACS Group, Inc. CEO Jason Hulse Murray sold 110,035 shares at $47.27 each on October 15, 2026, totaling roughly $5.2 million in a planned transaction.
- After the trade, Jason Hulse Murray holds 54,324,982 $PACS shares, down 0.20% from before the trade.
- Major institutions adjusted their positions recently, with Cohen & Steers Inc. trimming its holdings while American Century Companies added shares.
- PACS Group trades around $46.76 with a P/E ratio of 27.4 and anticipates reporting earnings on November 9, 2026.
Get $PACS trade alerts by text
We text you when insiders, Congress or big funds trade $PACS. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated PACS Group, Inc. alert may contain errors. Disclosures
PACS Group, Inc. (NYSE: PACS) CEO Jason Hulse Murray sold 110,035 shares of the company on October 15, 2026. According to a Form 4 filed with the SEC, the shares were sold at a price of $47.27 each, for a total value of about $5.2 million.
Inside Jason Hulse Murray's PACS Trade
The transaction involved 110,035 shares executed under a pre-arranged Rule 10b5-1 plan. The stock closed at $47.75 on the day of the sale. Murray serves as the Co-Founder, CEO and Chairman of the health care property and facility operator.
Other Institutional Activity in PACS Group
Cohen & Steers Inc. reduced its holdings by 780,054 shares, ending with 8,343,381 shares valued at about $391.4 million. Crewe Advisors LLC grew its holdings by 553,034 shares, ending with 3,307,188 shares worth about $155.1 million. American Century Companies Inc added 1,298,580 shares for a total of 3,108,196 shares worth about $145.8 million. Ameriprise Financial, Inc. grew its stake by 873,697 shares, ending with 1,995,116 shares valued at about $93.6 million. Alyeska Investment Group, L.p. trimmed its position by 1,463,403 shares, holding 1,539,065 shares worth about $72.2 million.
PACS Group, Inc. Stock Down 2.1%
The stock recently traded around $46.76. PACS Group has a market capitalization of roughly $7.43 billion and a P/E ratio of 27.43.
Recent Earnings
The company generated $5.55 billion in trailing-twelve-month revenue with earnings of $1.71 per share. Its next quarterly financial update is scheduled for November 9, 2026.
Insider Buying and Selling at PACS Group, Inc.
Other insiders also completed transactions prior to this sale. Director Mark Hancock sold 300,000 shares worth about $13.0 million on September 15, 2026. President Joshua Jergensen sold 40,000 shares worth about $1.7 million on September 16, 2026. Jason Hulse Murray previously sold 83,308 shares worth about $3.5 million on October 5, 2026, and another 36,692 shares worth about $1.6 million on October 7, 2026.
Analysts Set New Price Targets
UBS maintains a Buy rating with a $60.00 price target. RBC Capital maintains an Outperform rating with a $57.00 price target. Truist Securities maintains a Buy rating with a $62.00 target. Oppenheimer holds an Outperform rating with a $57.00 target, while JP Morgan maintains an Overweight rating with a $58.00 target. Analysts collectively rate the stock a strong buy with a mean target price of $59.00 across six opinions.
About PACS Group, Inc.
Headquartered in Salt Lake City, Utah, PACS Group operates skilled nursing facilities, assisted living locations, and senior care properties across the United States. The company acquires and leases health care real estate to support senior living services.
Bottom Line
Investors are keeping an eye on upcoming earnings reports and ongoing insider transaction filings to track corporate leadership adjustments.
Source: Jason Hulse Murray's Form 4 filing on $PACS (Oct 15, 2026). Read the original filing: Form 4 filing on SEC EDGAR. Written by software, not financial advice. How we make alerts
